Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 27, 2021, the Board of Directors (the "Board") of Cyclo Therapeutics, Inc. (the "Company"), upon the recommendation of the Compensation Committee of the Board (the "Committee"), approved increases in the annual base salary and target bonuses for the Company's executive officers, effective September 1, 2021, as set forth below:



                                                                       Target Bonus
                                                                      as Percentage
Officer                                             Base Salary       of Base Salary
N. Scott Fine (Chief Executive Officer)               $525,000             50%
Michael Lisjak (Chief Regulatory Officer)             $333,000             35%
Sharon Hrynkow (Chief Scientific Officer)             $323,000             35%
Joshua Fine (Chief Financial Officer)                 $326,000             40%
Jeffrey Tate (Chief Operating Officer)                $300,000             35%

In addition, following the Committee's recommendation, the Board also approved a compensation program for non-employee directors under which each such director will receive (i) an initial option to purchase 6,700 shares of the Company' common stock, (ii) an annual option to purchase 3,350 shares of the Company' common stock, and (iii) and the following annual compensation:



                                      Member       Chair
Board of Directors                    $40,000     $70,000
Audit Committee                        $7,500     $15,000
Compensation Committee                 $5,500     $11,000

Nominating and Governance Committee $4,000 $8,000

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses